HITACHI/SINGTEL
26.8.2024 03:01:25 CEST | Business Wire | Press release
Singtel and Hitachi, Ltd. (TSE: 6501) have signed a Memorandum of Understanding (MOU) to collaborate on next-generation data centers and GPU Cloud in Japan and potentially the wider Asia Pacific region under the lead of Singtel's Digital InfraCo unit. The strategic partnership will combine Singtel’s extensive data center and connectivity expertise and technology platforms with Hitachi’s differentiating capability that enables end-to-end data center integration including green power solutions, cooling systems, storage infrastructure and data management. Together, the companies intend to sustainably enhance data center performance and capabilities, thereby accelerating AI adoption and digital transformation of enterprises.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240825413497/en/
From left to right: Bill Chang, CEO of Singtel’s Digital InfraCo; Toshiaki Tokunaga, Executive Vice President, Hitachi, Ltd. (Photo: Business Wire)
Notably, the agreement expands on a partnership announced by the companies in June 2024*1 to trial and integrate Singtel’s Paragon, the all-in-one orchestration platform for 5G, edge computing and cloud, with Hitachi’s AI applications for Hitachi’s manufacturing operations as well as enterprise customers. Through Singtel’s Paragon platform and Hitachi’s deep AI expertise, both companies aim to address the complexities faced by customers when deploying AI capabilities.
*1 Press release (June 27, 2024) ”Singtel and Hitachi Digital Partner to Accelerate Industrial AI Solutions”
https://www.hitachi.com/New/cnews/month/2024/06/240628a.html
With the rapidly growing demand for AI and cloud services, Japan has become one of the largest and fastest growing data center markets in the Asia Pacific region. The market is expected to achieve a compound annual growth rate of 9.8% and reach US$5 billion by 2028*2.
*2 Structure Research, Japan (Tokyo & Osaka) DCI Report 2023: Data Centre Colocation, Hyperscale Cloud & Interconnection
Mr. Bill Chang, CEO of Singtel’s Digital InfraCo, said, “Our strategic partnership with Hitachi, a leader in digital systems and services fields, opens up new opportunities in a strategically important and expanding Japanese market. Building a strong ecosystem of partners has always been a priority at Singtel to better serve our customers and broaden our global reach. We look forward to bringing our collective expertise, digital assets and solutions to help more enterprises innovate and transform their businesses and operations through the cloud and AI. As we scale our digital capabilities with our partners like Hitachi, we aim to become a leader in the Asia Pacific region.”
Singtel carved out Digital InfraCo in mid-2023 to serve as a catalyst for innovation and economic growth for Asia Pacific’s digital economies. Digital InfraCo’s portfolio includes Nxera, its regional data center arm, subsea cable, and satellite businesses, and Paragon platform which are all crucial to advancing AI in the region. Digital InfraCo plans to launch GPU-as-a-Service (GPUaaS) later this year to better support enterprise AI adoption.
Mr. Toshiaki Tokunaga, Executive Vice President and Executive Officer at Hitachi, said, “Since its inception, Hitachi’s corporate philosophy has centered on addressing the challenges faced by customers and society. As generative AI continues to drive new innovations, the issues of environmental impact due to rising electricity demand is becoming more prominent. Striking a balance between these two factors is a significant mission for Hitachi’s Social Innovation Business. We are delighted to embark on this mission through our strategic alliance with Singtel. By combining Singtel's expertise in the development and operation of sustainable data centers with the comprehensive capabilities of the Hitachi Group, ranging from green power solutions to facility and data management, we aim to enable companies to utilize data centers in an intelligent and environmentally conscious manner; ultimately achieving continuous innovation while promoting sustainability.”
AI-driven data center expansion is a major opportunity for Hitachi’s Social Innovation business expansion and its group businesses such as Hitachi Digital Services, Hitachi Energy and others as the expansion calls for the successful integration of all areas where Hitachi uniquely excels: information technology, operational technology and products.
The key areas covered by the MOU are:
Explore next-generation data center collaboration in Japan and Asia Pacific to address AI demand: Nxera and Hitachi will explore opportunities to develop data centers across Japan and the rest of the Asia Pacific region. With the continued growth in cloud and AI momentum, it is important to operate smart and environmentally sustainable data centers through high efficiency, high quality data center management. Such an initiative would draw on Nxera’s expertise in data center design, building and operation along with Hitachi’s expertise in the production and delivery of data-center-focused equipment, next-generation energy solutions and advanced IT systems management that ensure stable operations within data center environments.
Nxera is developing a platform of sustainable, hyper-connected AI-ready data centers in the region with a total capacity of more than 200MW in addition to 62MW of existing capacity in Singapore.
Combine Singtel's GPU platform with Hitachi's AI expertise to develop enterprise applications: Hitachi will explore using Singtel’s GPUaaS for its internal AI applications and workloads. This effort would allow Hitachi to verify complementary Singtel-based benefits that can enhance Hitachi’s high-performance machine learning, generative AI, and other digital technologies and solutions. Subsequently, it would provide an opportunity for both companies to define more power-efficient methodologies that could advance any enterprise’s sustainability goals.
Based on the results of Hitachi’s internal GPUaaS verification, the companies may also explore the co-creation of enterprise-grade applications that combines Hitachi's expertise, including its generative AI technologies and platform, with Singtel's GPU cloud and Paragon platform. The aim is to further reduce customer development and deployment times as well as management and deployment overhead for AI applications.
About Singtel
Singtel is a leading Asian communications technology group, operating next-generation connectivity, digital infrastructure and digital businesses including regional data centre arm Nxera and regional IT services arm NCS. The Group has presence in Asia, Australia and Africa and reaches over 780 million mobile customers in 21 countries.
For consumers, Singtel delivers a complete and integrated suite of services, including mobile, broadband and TV. For enterprises, Singtel offers a complementary array of workforce mobility solutions, data hosting, cloud, network infrastructure, analytics and cyber security capabilities.
Singtel is dedicated to continuous innovation, harnessing technology to create new and exciting customer experiences, support enterprises in their digital transformation and shape a more sustainable, digital future.
For more information, visit www.singtel.com.
About Hitachi, Ltd.
Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the business structure of “Digital Systems & Services” - supporting our customers’ digital transformation; “Green Energy & Mobility” - contributing to a decarbonized society through energy and railway systems, and “Connective Industries” - connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s consolidated revenues for fiscal year 2022 (ended March 31, 2023) totaled 10,881.1 billion yen, with 696 consolidated subsidiaries and approximately 320,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240825413497/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom